Ben Synth explores how GLP-1 drugs like Ozempic and Wegovy—prescribed for diabetes and weight loss—are unexpectedly reducing alcohol cravings by modulating brain reward circuits. From rodent studies to clinical trials and patient reports, we examine the neuroscience behind why people are losing interest in drinking without willpower or withdrawal, and what this means for addiction treatment.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
Show More
Show Less